Anders Åhlin

2.9k total citations
37 papers, 2.2k citations indexed

About

Anders Åhlin is a scholar working on Immunology, Molecular Biology and Pharmacology. According to data from OpenAlex, Anders Åhlin has authored 37 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 13 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Anders Åhlin's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (17 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Complement system in diseases (5 papers). Anders Åhlin is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (17 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Complement system in diseases (5 papers). Anders Åhlin collaborates with scholars based in Sweden, Netherlands and United States. Anders Åhlin's co-authors include Dirk Roos, Martin de Boer, Bengt Fadeel, Jan‐Inge Henter, Mark B. Hampton, Sten Orrenius, Ewa Bernatowska, Jan Palmblad, Weening Rs and Henrik Nybäck and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and PLoS ONE.

In The Last Decade

Anders Åhlin

33 papers receiving 2.1k citations

Peers

Countries citing papers authored by Anders Åhlin

Since Specialization

Citations

This map shows the geographic impact of Anders Åhlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Åhlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Åhlin more than expected).

Fields of papers citing papers by Anders Åhlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Åhlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Åhlin. The network helps show where Anders Åhlin may publish in the future.

Co-authorship network of co-authors of Anders Åhlin

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Åhlin. A scholar is included among the top collaborators of Anders Åhlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Åhlin. Anders Åhlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	[Acute splenic sequestration in children with sickle cell disease--an overview]. 2016 ·PubMed ·Fredrik Larsson, Anders Åhlin, Mats Heyman, Jonas Abrahamsson	2
2	Allogeneic haematopoietic stem cell transplantation in the treatment of human C1q deficiency 2015 ·Molecular Immunology ·Richard F. Olsson, Stefan Hagelberg, (unknown), Olle Ringdén, Anders Åhlin	1
3	Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Human C1q Deficiency 2015 ·Transplantation ·Richard F. Olsson, Stefan Hagelberg, (unknown), Olle Ringdén, Lennart Truedsson, Anders Åhlin	26
4	Chronic granulomatous disease – conventional treatment vs. hematopoietic stem cell transplantation 2014 ·Current Opinion in Hematology ·Anders Åhlin, Anders Fasth	30
5	Allogeneic bone marrow transplantation restores complement function in human hereditary C1q deficiency 2012 ·Immunobiology ·Richard F. Olsson, Stefan Hagelberg, Olle Ringdén, Lennart Truedsson, Anders Åhlin	2
6	Molecular basis of hereditary C1q deficiency—revisited: identification of several novel disease-causing mutations 2011 ·Genes and Immunity ·Lone Schejbel, Lillemor Skattum, Stefan Hagelberg, Anders Åhlin, (unknown), Stefan Berg, Ferah Genel, Lennart Truedsson, Peter Garred	74
7	Nurses - psychiatrists' main collaborators when treating women with postpartum psychosis 2010 ·Journal of Psychiatric and Mental Health Nursing ·(unknown), Anders Åhlin, Ginette G. Ferszt, Kerstin Nilsson	8
8	Chronic Granulomatous Disease: The European Experience 2009 ·PLoS ONE ·J. Merlijn van den Berg, (unknown), Anders Åhlin, Bernd H. Belohradsky, Ewa Bernatowska, L Corbeel, Teresa Español, Alain Fischer, Magdalena Kurenko-Deptuch, Richard Mouy, Theoni Petropoulou, Joachim Roesler, Reinhard Seger, Marie José Stasia, Niels Henrik Valerius, Ron S. Weening, Baruch Wolach, Dirk Roos, Taco W. Kuijpers	455
9	Clinical experiences and biochemical findings with tacrine (THA) 2009 ·Acta Neurologica Scandinavica ·Henrik Nybäck, Moustapha Hassan, (unknown), Anders Åhlin	0
10	Chronic granulomatous disease caused by mutations other than the common GT deletion inNCF1, the gene encoding the p47^phoxcomponent of the phagocyte NADPH oxidase 2006 ·Human Mutation ·Dirk Roos, Martin de Boer, Mustafa Yavuz Köker, Jan P. Dekker, Vinita Singh‐Gupta, Anders Åhlin, Jan Palmblad, Özden Sanal, Magdalena Kurenko-Deptuch, Stephen Jolles, Baruch Wolach	41
11	Efficacy and safety of two different rG‐CSF preparations in the treatment of patients with severe congenital neutropenia* 2004 ·British Journal of Haematology ·Göran Carlsson, Anders Åhlin, Göran Dahllöf, Göran Elinder, Jan‐Inge Henter, Jan Palmblad	28
12	Abberant Cytosolic Calcium Ion Mobilization in Chronic Granulomatous Disease Neutrophils 2004 ·Inflammation ·Jan Palmblad, Anders Hansson, Mikael Heimbürger, Anders Åhlin	1
13	A new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous disease 2000 ·European Journal of Human Genetics ·Christof Meischl, Martin de Boer, Anders Åhlin, Dirk Roos	87
14	Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease. 1996 ·The Journal of Experimental Medicine ·Jeanette H.W. Leusen, (unknown), P. M. Hilarius, Anders Åhlin, Jan Palmblad, Smith Rjh, Dagmar Diekmann, Anne Hall, AJ Verhoeven, Dirk Roos	70
15	Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease 1996 ·Blood ·Dirk Roos, Martin de Boer, Futoshi Kuribayashi, C. Meischl, Weening Rs, Anthony W. Segal, Anders Åhlin, K Német, JP Hossle, Ewa Bernatowska, Helen Middleton‐Price	345
16	Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden 1995 ·Acta Paediatrica ·Anders Åhlin, Martin de Boer, Dirk Roos, Jeanette H.W. Leusen, Smith Rjh, Ulf Sundin, Hodjattallah Rabbani, Jan Palmblad, Göran Elinder	80
17	Neutrophil membrane potential changes and homotypic aggregation kinetics are pH-dependent: studies of chronic granulomatous disease. 1995 ·PubMed ·Anders Åhlin, Hans Gyllenhammar, B Ringertz, Jan Palmblad	17
18	PET studies of the uptake of (S)- and (R)-[11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo 1994 ·Psychopharmacology ·Henrik Nybäck, Christer Halldin, Anders Åhlin, Margareta Curvall, Lars I. Eriksson	84
19	A 40‐base‐pair duplication in the gp91‐phox gene leading to X‐linked chronic granulomatous disease 1993 ·European Journal Of Haematology ·Hodjattallah Rabbani, Martin de Boer, Anders Åhlin, Ulf Sundin, Göran Elinder, Lennart Hammarström, Jan Palmblad, Smith Rjh, Dirk Roos	11
20	Pharmacokinetics of tetrahydroaminoacridine 1992 ·International Clinical Psychopharmacology ·Anders Åhlin, Abdu Adem, (unknown), (unknown), Henrik Nybäck	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact